By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Signal Genetics has inked agreements to commercialize DiagnoCure's colorectal cancer test, acquire its CLIA service laboratory, and develop additional genomic cancer tests, the two companies announced today.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.
Hong Kong is using DNA phenotyping to shame litterers.
A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.
NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.